Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

[Strategy for treatment of acute lymphoblastic leukemia].

Kobayashi Y.

Rinsho Ketsueki. 2018;59(10):2019-2027. doi: 10.11406/rinketsu.59.2019. Review. Japanese.

PMID:
30305504
2.

[Current management of adult Philadelphia chromosome-positive acute lymphoblastic leukemia].

Onizuka M.

Rinsho Ketsueki. 2018;59(10):2028-2035. doi: 10.11406/rinketsu.59.2028. Review. Japanese.

PMID:
30305505
3.

Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia.

Jeha S, Coustan-Smith E, Pei D, Sandlund JT, Rubnitz JE, Howard SC, Inaba H, Bhojwani D, Metzger ML, Cheng C, Choi JK, Jacobsen J, Shurtleff SA, Raimondi S, Ribeiro RC, Pui CH, Campana D.

Cancer. 2014 May 15;120(10):1514-9. doi: 10.1002/cncr.28598. Epub 2014 Feb 5.

4.
5.

Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes.

Kebriaei P, Saliba R, Rondon G, Chiattone A, Luthra R, Anderlini P, Andersson B, Shpall E, Popat U, Jones R, Worth L, Ravandi F, Thomas D, O'Brien S, Kantarjian H, de Lima M, Giralt S, Champlin R.

Biol Blood Marrow Transplant. 2012 Apr;18(4):584-92. doi: 10.1016/j.bbmt.2011.08.011. Epub 2011 Aug 23.

6.

Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus.

Chamseddine AN, Willekens C, De Botton S, Bourhis JH.

Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S129-40. doi: 10.1016/j.clml.2015.05.001.

PMID:
26297265
7.

Hematopoietic Stem Cell Transplantation for Adult Philadelphia-Negative Acute Lymphoblastic Leukemia in the First Complete Remission in the Era of Minimal Residual Disease.

Bourlon C, Lacayo-Leñero D, Inclán-Alarcón SI, Demichelis-Gómez R.

Curr Oncol Rep. 2018 Mar 26;20(4):36. doi: 10.1007/s11912-018-0679-9. Review.

PMID:
29577208
8.

Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.

Aldoss I, Stiller T, Cao TM, Palmer JM, Thomas SH, Forman SJ, Pullarkat V.

Biol Blood Marrow Transplant. 2015 Jul;21(7):1326-9. doi: 10.1016/j.bbmt.2015.03.021. Epub 2015 Apr 1.

9.

Tyrosine kinase inhibitor use in pediatric Philadelphia chromosome-positive acute lymphoblastic anemia.

Hunger SP.

Hematology Am Soc Hematol Educ Program. 2011;2011:361-5. doi: 10.1182/asheducation-2011.1.361. Review.

PMID:
22160058
10.

[Second-generation tyrosine kinase inhibitors combined with allogeneic hematopoietic stem cell transplant for Philadelphia chromosome positive leukemia].

Yu X, Li C, Wu X, Ye L, Liu H, Ma C, Ma J, Gu C, Wu D.

Zhonghua Xue Ye Xue Za Zhi. 2014 Feb;35(2):129-33. doi: 10.3760/cma.j.issn.0253-2727.2014.02.015. Chinese.

PMID:
24606654
11.

Hematopoietic stem cell transplant in adults with acute lymphoblastic leukemia: the present state.

Saadeh SS, Litzow MR.

Expert Rev Hematol. 2018 Mar;11(3):195-207. doi: 10.1080/17474086.2018.1433030. Epub 2018 Feb 7. Review.

PMID:
29376437
12.

Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?

DeFilipp Z, Langston AA, Chen Z, Zhang C, Arellano ML, El Rassi F, Flowers CR, Kota VK, Al-Kadhimi Z, Veldman R, Jillella AP, Lonial S, Waller EK, Khoury HJ.

Clin Lymphoma Myeloma Leuk. 2016 Aug;16(8):466-471.e1. doi: 10.1016/j.clml.2016.04.017. Epub 2016 May 5.

PMID:
27297665
13.

Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Giebel S, Czyz A, Ottmann O, Baron F, Brissot E, Ciceri F, Cornelissen JJ, Esteve J, Gorin NC, Savani B, Schmid C, Mohty M, Nagler A.

Cancer. 2016 Oct;122(19):2941-51. doi: 10.1002/cncr.30130. Epub 2016 Jun 16. Review.

14.

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.

Brissot E, Labopin M, Beckers MM, Socié G, Rambaldi A, Volin L, Finke J, Lenhoff S, Kröger N, Ossenkoppele GJ, Craddock CF, Yakoub-Agha I, Gürman G, Russell NH, Aljurf M, Potter MN, Nagler A, Ottmann O, Cornelissen JJ, Esteve J, Mohty M.

Haematologica. 2015 Mar;100(3):392-9. doi: 10.3324/haematol.2014.116954. Epub 2014 Dec 19.

15.

Patients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutation.

Egan DN, Beppu L, Radich JP.

Biol Blood Marrow Transplant. 2015 Jan;21(1):184-9. doi: 10.1016/j.bbmt.2014.09.012. Epub 2014 Oct 6.

16.

[Efficacy comparison of sequential treatment with first-line administration of second-generation and first-generation tyrosine kinase inhibitors in patients with Ph+ acute lymphoblastic leukemia followed by allogeneic hematopoietic stem cell transplantation].

Yang F, Cai WZ, Yang XD, Chen SN, Tang XW, Sun AN, Wu DP, Qian WQ, Qiu HY.

Zhonghua Xue Ye Xue Za Zhi. 2018 Feb 14;39(2):110-115. doi: 10.3760/cma.j.issn.0253-2727.2018.02.007. Chinese.

PMID:
29562444
17.

Tyrosine Kinase Inhibitor for Treatment of Adult Allogeneic Hematopoietic Stem Cell Transplantation Candidate with Philadelphia-Positive Acute Lymphoblastic Leukemia.

Wang L, Liu DH.

Chin Med J (Engl). 2017 Jan 20;130(2):127-129. doi: 10.4103/0366-6999.197976. No abstract available.

19.

Prognostic factors and outcomes of unrelated bone marrow transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) pre-treated with tyrosine kinase inhibitors.

Yoshimura T, Nakane T, Hirose A, Koh H, Nakamae M, Aimoto M, Nishimoto M, Hayashi Y, Terada Y, Nakamae H, Hino M.

Osaka City Med J. 2013 Jun;59(1):9-21.

PMID:
23909077
20.

Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.

Chen H, Liu KY, Xu LP, Chen YH, Han W, Zhang XH, Wang Y, Qin YZ, Liu YR, Huang XJ.

Biol Blood Marrow Transplant. 2015 Jun;21(6):1110-6. doi: 10.1016/j.bbmt.2015.02.009. Epub 2015 Feb 16.

Supplemental Content

Support Center